The Antiosteoporotic Effect of Oxymatrine Compared to Testosterone in Orchiectomized Rats

Overview

Journal J Orthop Surg Res

Publisher Biomed Central

Date 2025 Jan 9

PMID 39780225

Authors

Anwaar M Shaban

Eman A Ali

Sara G Tayel

Sara Kamal Rizk

Dalia F El Agamy

Affiliations

Soon will be listed here.

Abstract

Background: Castration of adult male rats led to the development of osteoporosis. Oxidative stress and inflammatory factors have been identified as potential causative factors. Notably, oxymatrine (OMT) possesses potent anti-inflammatory and antioxidant activities. This study aims to elucidate the antiosteoporotic effects of OMT compared to testosterone in an orchiectomized (ORX) rat model of osteoporosis.

Methods: A total of 60 Wistar male rats were divided into the following groups: control (CTRL), surgery + no orchiectomy (SHAM), ORX, ORX + testosterone, and ORX + OMT. Urinary deoxypyridinoline (DPD), calcium (Ca), and phosphorus (P), as well as serum testosterone, parathormone (PTH), alkaline phosphatase (ALP), osteocalcin, N-telopeptide of type I collagen (NTX I), tartrate resistance acid phosphatase (TRAP), and total Ca and P levels were evaluated. Bone was assessed for malondialdehyde (MDA), reduced glutathione (GSH), interleukin 6 (IL-6), Kelch-like ECH-associated protein 1 (Keap1), nuclear factor erythroid 2-related factor 2 (Nrf2), heme oxygenase 1 (HO-1) expression, and receptor activator of nuclear factor κB ligand/ osteoprotegerin (RANKL/OPG) ratio. Bone dual-energy X-ray absorptiometry (DEXA) scan and histological and immunohistochemical studies were performed.

Results: Testosterone or OMT treatment ameliorated the reduced bone mineral density (BMD) and bone mineral content (BMC) in the DEXA scan and the changes in PTH and Ca levels. Compared to the ORX group, bone formation, and turnover markers were also significantly reversed in the treatment groups. Treatment with testosterone or OMT significantly reduced bone MDA, IL-6, Keap1, RANKL, and RANKL/OPG ratio, and significantly elevated bone GSH, Nrf2, and HO-1. Moreover, testosterone or OMT treatment has restored cortical bone thickness and osteocyte number and reduced bone levels of TNF-α in ORX rats. Consequently, treatment with either testosterone or OMT exhibited nearly equal therapeutic efficacy; however, neither of them could normalize the measured parameters.

Conclusion: OMT treatment showed equal efficacy compared to testosterone in ameliorating osteoporosis in ORX rats, possibly by improving some inflammatory and oxidative stress parameters.

References

Marahleh A, Kitaura H, Ohori F, Kishikawa A, Ogawa S, Shen W . TNF-α Directly Enhances Osteocyte RANKL Expression and Promotes Osteoclast Formation. Front Immunol. 2020; 10:2925. PMC: 6923682. DOI: 10.3389/fimmu.2019.02925. View

Boker K, Komrakova M, Fahrendorff L, Spelsberg B, Hoffmann D, Schilling A . Treatment of osteoporosis using a selective androgen receptor modulator ostarine in an orchiectomized rat model. Endocrine. 2023; 81(3):579-591. PMC: 10403398. DOI: 10.1007/s12020-023-03422-7. View

Kang S, Chen T, Hao Z, Yang X, Wang M, Zhang Z . Oxymatrine Alleviates Gentamicin-Induced Renal Injury in Rats. Molecules. 2022; 27(19). PMC: 9571404. DOI: 10.3390/molecules27196209. View

Lan X, Zhao J, Zhang Y, Chen Y, Liu Y, Xu F . Oxymatrine exerts organ- and tissue-protective effects by regulating inflammation, oxidative stress, apoptosis, and fibrosis: From bench to bedside. Pharmacol Res. 2019; 151:104541. DOI: 10.1016/j.phrs.2019.104541. View

Zhang X, Shi J, Lu Y, Ji R, Guan Z, Peng F . Mechanism of oxymatrine in the treatment of cryptosporidiosis through TNF/NF-κB signaling pathway based on network pharmacology and experimental validation. Sci Rep. 2024; 14(1):14469. PMC: 11196726. DOI: 10.1038/s41598-024-65362-0. View

Sophocleous A, Idris A . Ovariectomy/Orchiectomy in Rodents. Methods Mol Biol. 2019; 1914:261-267. DOI: 10.1007/978-1-4939-8997-3_13. View

Beranger G, Djedaini M, Battaglia S, Roux C, Scheideler M, Heymann D . Oxytocin reverses osteoporosis in a sex-dependent manner. Front Endocrinol (Lausanne). 2015; 6:81. PMC: 4437051. DOI: 10.3389/fendo.2015.00081. View

Zhou K, Liu D, Jin Y, Xia W, Zhang P, Zhou Z . Oxymatrine ameliorates osteoarthritis via the Nrf2/NF-κB axis in vitro and in vivo. Chem Biol Interact. 2023; 380:110539. DOI: 10.1016/j.cbi.2023.110539. View

Migliorini F, Maffulli N, Colarossi G, Eschweiler J, Tingart M, Betsch M . Effect of drugs on bone mineral density in postmenopausal osteoporosis: a Bayesian network meta-analysis. J Orthop Surg Res. 2021; 16(1):533. PMC: 8393477. DOI: 10.1186/s13018-021-02678-x. View

10.

Filipovic B, Sosic-Jurjevic B, Ajdzanovic V, Pantelic J, Nestorovic N, Milosevic V . The effects of sex steroids on thyroid C cells and trabecular bone structure in the rat model of male osteoporosis. J Anat. 2012; 222(3):313-20. PMC: 3582251. DOI: 10.1111/joa.12013. View

11.

Singh S, Kumar D, Lal A . Serum Osteocalcin as a Diagnostic Biomarker for Primary Osteoporosis in Women. J Clin Diagn Res. 2015; 9(8):RC04-7. PMC: 4576601. DOI: 10.7860/JCDR/2015/14857.6318. View

12.

Zhang G, Cui R, Kang Y, Qi C, Ji X, Zhang T . Testosterone propionate activated the Nrf2-ARE pathway in ageing rats and ameliorated the age-related changes in liver. Sci Rep. 2019; 9(1):18619. PMC: 6901587. DOI: 10.1038/s41598-019-55148-0. View

13.

Migliorini F, Maffulli N, Spiezia F, Peretti G, Tingart M, Giorgino R . Potential of biomarkers during pharmacological therapy setting for postmenopausal osteoporosis: a systematic review. J Orthop Surg Res. 2021; 16(1):351. PMC: 8165809. DOI: 10.1186/s13018-021-02497-0. View

14.

Ryu S, Ryu D, Kim J, Park J, Kim K, Chin D . Bone Mineral Density Changes after Orchiectomy using a Scrotal Approach in Rats. Korean J Spine. 2015; 12(2):55-9. PMC: 4513169. DOI: 10.14245/kjs.2015.12.2.55. View

15.

Saadiah Abdul Razak H, Shuid A, Naina Mohamed I . Combined Effects of Eurycoma longifolia and Testosterone on Androgen-Deficient Osteoporosis in a Male Rat Model. Evid Based Complement Alternat Med. 2012; 2012:872406. PMC: 3424595. DOI: 10.1155/2012/872406. View

16.

Lo E, Rodriguez K, Pastuszak A, Khera M . Alternatives to Testosterone Therapy: A Review. Sex Med Rev. 2017; 6(1):106-113. DOI: 10.1016/j.sxmr.2017.09.004. View

17.

Cheng X, Zhao C . The correlation between serum levels of alkaline phosphatase and bone mineral density in adults aged 20 to 59 years. Medicine (Baltimore). 2023; 102(32):e34755. PMC: 10419484. DOI: 10.1097/MD.0000000000034755. View

18.

Tu W, Wang H, Li S, Liu Q, Sha H . The Anti-Inflammatory and Anti-Oxidant Mechanisms of the Keap1/Nrf2/ARE Signaling Pathway in Chronic Diseases. Aging Dis. 2019; 10(3):637-651. PMC: 6538222. DOI: 10.14336/AD.2018.0513. View

19.

Azizieh F, Shehab D, Jarallah K, Gupta R, Raghupathy R . Circulatory Levels of RANKL, OPG, and Oxidative Stress Markers in Postmenopausal Women With Normal or Low Bone Mineral Density. Biomark Insights. 2019; 14:1177271919843825. PMC: 6700864. DOI: 10.1177/1177271919843825. View

20.

Jota-Baptista C, Faustino-Rocha A, Fardilha M, Ferreira R, Oliveira P, Regueiro-Purrinos M . Effects of testosterone and exercise training on bone microstructure of rats. Vet World. 2022; 15(3):627-633. PMC: 9047140. DOI: 10.14202/vetworld.2022.627-633. View